To better understand molecular mechanism underlying CMLD-2 effects on thyroid cancer cells, we focused on MAD2, a HuR-mRNA target known to be involved in cancer26–28 and overexpressed in thyroid neoplasms29. The gene discussed is ELAVL1; the disease is thyroid gland carcinoma.